Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2025-12-26 @ 3:50 AM
NCT ID: NCT01580618
Description: Intrapleural hemorrhage was the specific adverse event which can be directly related to the presence of a chest tube and/or infusion of fluid into the pleural space.
Frequency Threshold: 5
Time Frame: From time of randomization until the time of pleural catheter removal.
Study: NCT01580618
Study Brief: Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Normal Saline Loculated pleural effusion infused with normal saline twice a day for three days. None None 0 7 0 7 View
TNKase Loculated pleural effusion infused with TNK twice a day for three days. None None 1 13 0 13 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
intrapleural hemorrhage SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Other Events(If Any):